BMY - Bristol-Myers S Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 TVIX (7.91%) DGAZ (2.48%) IWM (-0.22%) UGAZ (-2.25%) VBIV (2.63%) VXX (5.15%) LMRK (0.65%) KSS (0.46%) KR (-0.55%) KO (-1.12%) IRM (-0.47%) IMGN (5.76%) GSK (0.75%) FEYE (0.43%) FDX (-2.41%) F (0.77%) EXAS (0.56%) EPZM (-0.81%) ECA (-0.41%) DISH (-2.54%) DIS (%) COST (-0.52%) CHWY (-3.8%) CC (-1.28%) APLE (%)

BMY - Bristol-Myers Squibb...

$50.57 0.5[%]

15 mins delayed data

People also watch : LLY | AZN | JNJ | SNY | ABBV | PFE

+Watchlist

5 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$50.07	Open	$50.07
Volume	13.58M	Market Cap	80.856B
Yield	0.033%	Last Dividend	$1.63

Day

52 Week

Mike Quigley has personal motivation lea...	1:52 PM
Mike Quigley’s passion for science led him to marine biology, but his devotion for his mother took him into one of the hottest areas of cancer researc...

5 Safe Bets for a Rocky Market	1:29 PM
Here are 5 companies with proven track records.

iShares Reveals New Corporate Bond ETF ‘...	8:00 AM
iShares on Thursday launched a new corporate bond ETF on NYSE Arca: the iShares iBonds Dec 2029 Team Corporate ETF (IBDU n/a). IBDU seeks to track the...

Zacks Value Trader Highlights: Exact Sci...	7:49 AM
Zacks Value Trader Highlights: Exact Sciences, Edwards Lifesciences, Bristol Myers-Squibb, Occidental Petroleum and Exxon Mobil

3 Big Biotech Stocks Worth Adding to You...	5:31 AM
We highlight a few key biotech stocks that surpass the sector so far in 2019 and are likely to witness a winning run in the near term.

Bristol-Myers Squibb to Hold Investor We...	3:59 AM
Bristol-Myers Squibb Company will host a webcast on Saturday, September 28, 2019 at 7:30 p.m. CEST to discuss data presented at the European Society o...

Does Bristol-Myers Squibb Company's ...	09/19/19
Giovanni Caforio has been the CEO of Bristol-Myers Squibb Company (NYSE:BMY) since 2015. This analysis aims first to...

11 Most Aggressively Shorted Stocks	09/19/19
Traders also look at the activity of short sellers for trading opportunities. Sometimes, stocks with a large amount of short selling activity could be...

Stock Investors: Do You Need a Late Cycl...	09/19/19
The financial media keeps talking about the economy being in the late cycle but that doesn't mean you can't be buying stocks.

Bristol-Myers Squibb Is Set to Emerge Fr...	09/19/19
Bristol-Myers Squibb today was upgraded to buy by TheStreet.com's quantitative service. Let's see whether the technical analysts and the qua...

Bristol-Myers Squibb Research at ESMO De...	09/19/19
Overall survival data from CheckMate -227 Part 1 evaluating Opdivo plus low-dose Yervoy in advanced non-small cell lung cancer featured in ESMO Presid...

ANALYST RATINGS

5 analyst ratings (Last 6 months)

60.00 %

Strong Buy + Buy

Price Target (PT)

Hold rating	09/03/19
Bank of America maintains Neutral rating and raises Price Target from $46.00 to $49.00

Hold rating	06/13/19
UBS maintains Neutral rating and lowers Price Target from $55.00 to $51.00

Buy rating	05/28/19
Goldman Sachs initiates coverage with Buy rating and announces Price Target of $54.00

Strong Buy rating	05/03/19
Barclays upgrades from Equal-Weight to Overweight rating and raises Price Target from $53.00 to $55.00

Strong Buy rating	04/17/19
BMO Capital maintains Outperform rating and raises Price Target from $62.00 to $63.00

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $BMY

Service Name	Trader	% Success
Option Superstars	James Catzen	76.00 %	Subscribe
Alpha Swing Trades	Jonathan	69.00 %	Follow
Options Eagle	George	59.00 %	Follow
Options Marc	Marc M	55.00 %	Follow
Best Trading Ideas	Best Trading Ideas	53.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.